Y-mabs announces data to be presented at the 55th congress of the international society of pediatric oncology

New york, sept. 21, 2023 (globe newswire) -- y-mabs therapeutics, inc. (the "company" or "y-mabs") (nasdaq: ymab), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today announced the acceptance of four abstracts at the 55th congress of the international society of pediatric oncology ("siop") to be held october 11-14, 2023 in ottawa, canada.
YMAB Ratings Summary
YMAB Quant Ranking